Comparison 48. AbobotulinumtoxinA 50 units versus placebo, three cycles of treatment in glabellar lines.
| Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
|---|---|---|---|---|
| 48.1 Participant assessment of success by analysing scores and scales | 1 | Risk Ratio (M‐H, Random, 95% CI) | Totals not selected | |
| 48.1.1 4 weeks | 1 | Risk Ratio (M‐H, Random, 95% CI) | Totals not selected | |
| 48.2 Physician assessment of success by analysing scores and scales | 1 | Risk Ratio (M‐H, Random, 95% CI) | Totals not selected | |
| 48.2.1 4 weeks | 1 | Risk Ratio (M‐H, Random, 95% CI) | Totals not selected | |
| 48.3 Total adverse events | 1 | Risk Ratio (M‐H, Random, 95% CI) | Totals not selected |